{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T10:25:46Z","timestamp":1787048746377,"version":"build-2736575974"},"reference-count":69,"publisher":"American Chemical Society (ACS)","issue":"10","license":[{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T00:00:00Z","timestamp":1598400000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-045"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Artificial intelligence and multiobjective optimization represent promising solutions to bridge chemical and biological landscapes by addressing the automated de novo design of compounds as a result of a humanlike creative process. In the present study, we conceived a novel pair-based multiobjective approach implemented in an adapted SMILES generative algorithm based on recurrent neural networks for the automated de novo design of new molecules whose overall features are optimized by finding the best trade-offs among relevant physicochemical properties (MW, logP, HBA, HBD) and additional similarity-based constraints biasing specific biological targets. In this respect, we carried out the de novo design of chemical libraries targeting neuraminidase, acetylcholinesterase, and the main protease of severe acute respiratory syndrome coronavirus 2. Several quality metrics were employed to assess drug-likeness, chemical feasibility, diversity content, and validity. Molecular docking was finally carried out to better evaluate the scoring and posing of the de novo generated molecules with respect to X-ray cognate ligands of the corresponding molecular counterparts. Our results indicate that artificial intelligence and multiobjective optimization allow us to capture the latent links joining chemical and biological aspects, thus providing easy-to-use options for customizable design strategies, which are especially effective for both lead generation and lead optimization. The algorithm is freely downloadable at https:\/\/github.com\/alberdom88\/moo-denovo and all of the data are available as Supporting Information.<\/jats:p>","DOI":"10.1021\/acs.jcim.0c00517","type":"journal-article","created":{"date-parts":[[2020,8,26]],"date-time":"2020-08-26T10:39:24Z","timestamp":1598438364000},"page":"4582-4593","source":"Crossref","is-referenced-by-count":85,"title":["<i>De Novo<\/i>\n                    Drug Design of Targeted Chemical\nLibraries Based on Artificial Intelligence and Pair-Based Multiobjective\nOptimization"],"prefix":"10.1021","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9475-9602","authenticated-orcid":true,"given":"Alberga","family":"Domenico","sequence":"first","affiliation":[{"name":"Universita\u0300 degli Studi di Bari \u201cAldo Moro\u201d , , Via E. Orabona, 4 , ,","place":["Bari, Italy, I-70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gambacorta","family":"Nicola","sequence":"additional","affiliation":[{"name":"Universita\u0300 degli Studi di Bari \u201cAldo Moro\u201d , , Via E. Orabona, 4 , ,","place":["Bari, Italy, I-70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisciuzzi","family":"Daniela","sequence":"additional","affiliation":[{"name":"Universita\u0300 degli Studi di Bari \u201cAldo Moro\u201d , , Via E. Orabona, 4 , ,","place":["Bari, Italy, I-70126"]},{"name":"Molecular Horizon srl , Via Montelino 32 , ,","place":["Bettona, Italy, 06084"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciriaco","family":"Fulvio","sequence":"additional","affiliation":[{"name":"Universita\u0300 degli Studi di Bari \u201cAldo Moro\u201d , , Via E. Orabona, 4 , ,","place":["Bari, Italy, I-70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amoroso","family":"Nicola","sequence":"additional","affiliation":[{"name":"Universita\u0300 degli Studi di Bari \u201cAldo Moro\u201d , , Via E. Orabona, 4 , ,","place":["Bari, Italy, I-70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6533-5539","authenticated-orcid":true,"given":"Nicolotti","family":"Orazio","sequence":"additional","affiliation":[{"name":"Universita\u0300 degli Studi di Bari \u201cAldo Moro\u201d , , Via E. Orabona, 4 , ,","place":["Bari, Italy, I-70126"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"2026081804371274100_cit1","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/nrd3368","article-title":"Impact\nof High-Throughput Screening in Biomedical Research","volume":"10","author":"Macarron","year":"2011","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026081804371274100_cit2","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1039\/c0md00020e","article-title":"Chemical Space\nas a Source for New Drugs","volume":"1","author":"Reymond","year":"2010","journal-title":"Med. Chem. Commun."},{"key":"2026081804371274100_cit3","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.cbpa.2004.04.003","article-title":"Pursuing the Leadlikeness Concept in Pharmaceutical\nResearch","volume":"8","author":"Hann","year":"2004","journal-title":"Curr. Opin. Chem. Biol."},{"key":"2026081804371274100_cit4","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1038\/nrd4609","article-title":"An Analysis of the\nAttrition of Drug Candidates from Four Major Pharmaceutical Companies","volume":"14","author":"Waring","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026081804371274100_cit5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1517\/17460441.2014.872624","article-title":"Balancing Novelty with Confined Chemical\nSpace in Modern Drug Discovery","volume":"9","author":"Medina-Franco","year":"2014","journal-title":"Expert Opin.\nDrug Discovery"},{"key":"2026081804371274100_cit6","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.ejmech.2017.07.037","article-title":"Novel Chemotypes\nTargeting Tubulin at the Colchicine Binding Site and Unbiasing P-Glycoprotein","volume":"139","author":"Mangiatordi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"2026081804371274100_cit7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/bib\/bbaa034","article-title":"Virtual\nScreening Web Servers: Designing\nChemical Probes and Drug Candidates in the Cyberspace","author":"Singh","year":"2020","journal-title":"Briefings Bioinf."},{"key":"2026081804371274100_cit8","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1021\/jm020919o","article-title":"Multiobjective\nOptimization in Quantitative Structure\u2013Activity Relationships:\nDeriving Accurate and Interpretable QSARs","volume":"45","author":"Nicolotti","year":"2002","journal-title":"J.\nMed. Chem."},{"key":"2026081804371274100_cit9","doi-asserted-by":"publisher","first-page":"2290","DOI":"10.1021\/ci9002409","article-title":"Improving Quantitative\nStructure\u2013Activity Relationships through Multiobjective Optimization","volume":"49","author":"Nicolotti","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804371274100_cit10","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1517\/17460441.2011.588696","article-title":"Strategies of Multi-objective Optimization in Drug\nDiscovery and Development","volume":"6","author":"Nicolotti","year":"2011","journal-title":"Expert Opin. Drug\nDiscovery"},{"key":"2026081804371274100_cit11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1038\/nrd1799","article-title":"Computer-Based de Novo\nDesign of Drug-like Molecules","volume":"4","author":"Schneider","year":"2005","journal-title":"Nat. Rev. Drug\nDiscovery"},{"key":"2026081804371274100_cit12","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1126\/science.257.5073.1078","article-title":"Structure-Based\nStrategies for Drug Design and Discovery","volume":"257","author":"Kuntz","year":"1992","journal-title":"Science"},{"key":"2026081804371274100_cit13","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1016\/j.drudis.2018.01.039","article-title":"The Rise of Deep Learning in Drug\nDiscovery","volume":"23","author":"Chen","year":"2018","journal-title":"Drug Discovery Today"},{"key":"2026081804371274100_cit14","doi-asserted-by":"publisher","first-page":"1538","DOI":"10.1016\/j.drudis.2018.05.010","article-title":"Machine Learning\nin Chemoinformatics and Drug Discovery","volume":"23","author":"Lo","year":"2018","journal-title":"Drug\nDiscovery Today"},{"key":"2026081804371274100_cit15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41573-019-0050-3","article-title":"Rethinking\nDrug Design in the Artificial Intelligence\nEra","author":"Schneider","year":"2019","journal-title":"Nat. Rev. Drug Discovery"},{"key":"2026081804371274100_cit16","doi-asserted-by":"publisher","first-page":"10792","DOI":"10.1002\/anie.201814681","article-title":"Automated De Novo Drug Design: Are\nWe Nearly There\nYet?","volume":"58","author":"Schneider","year":"2019","journal-title":"Angew. Chem., Int. Ed."},{"key":"2026081804371274100_cit17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s13321-018-0286-7","article-title":"Molecular Generative Model Based\non Conditional Variational Autoencoder for de Novo Molecular Design","volume":"10","author":"Lim","year":"2018","journal-title":"J. Cheminf."},{"key":"2026081804371274100_cit18","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1021\/acscentsci.7b00572","article-title":"Automatic\nChemical Design Using a Data-Driven Continuous Representation of Molecules","volume":"4","author":"Go\u0301mez-Bombarelli","year":"2018","journal-title":"ACS Cent. Sci."},{"key":"2026081804371274100_cit19","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1021\/acs.jcim.8b00751","article-title":"De Novo Molecular Design\nby Combining Deep Autoencoder\nRecurrent Neural Networks with Generative Topographic Mapping","volume":"59","author":"Sattarov","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804371274100_cit20","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1021\/acs.molpharmaceut.7b00346","article-title":"DruGAN: An\nAdvanced Generative Adversarial Autoencoder Model for de Novo Generation\nof New Molecules with Desired Molecular Properties in Silico","volume":"14","author":"Kadurin","year":"2017","journal-title":"Mol. Pharmaceutics"},{"key":"2026081804371274100_cit21","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1021\/acs.jcim.7b00690","article-title":"Reinforced\nAdversarial Neural Computer for de Novo Molecular Design","volume":"58","author":"Putin","year":"2018","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804371274100_cit22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s13321-019-0397-9","article-title":"A de Novo Molecular\nGeneration Method Using Latent Vector Based Generative Adversarial\nNetwork","volume":"11","author":"Prykhodko","year":"2019","journal-title":"J. Cheminf."},{"key":"2026081804371274100_cit23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13321-017-0235-x","article-title":"Molecular De-Novo Design\nthrough Deep Reinforcement Learning","volume":"9","author":"Olivecrona","year":"2017","journal-title":"J. Cheminf."},{"key":"2026081804371274100_cit24","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201700111","article-title":"Generative Recurrent Networks for\nDe Novo Drug Design","volume":"37","author":"Gupta","year":"2018","journal-title":"Mol. Inf."},{"key":"2026081804371274100_cit25","doi-asserted-by":"publisher","DOI":"10.1002\/minf.201700153","article-title":"De Novo Design\nof Bioactive Small Molecules by Artificial Intelligence","volume":"37","author":"Merk","year":"2018","journal-title":"Mol. Inform."},{"key":"2026081804371274100_cit26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aap7885","article-title":"Deep Reinforcement\nLearning for de\nNovo Drug Design","volume":"4","author":"Popova","year":"2018","journal-title":"Sci. Adv."},{"key":"2026081804371274100_cit27","doi-asserted-by":"publisher","first-page":"D930","DOI":"10.1093\/nar\/gky1075","article-title":"ChEMBL: Towards\nDirect Deposition of Bioassay Data","volume":"47","author":"Mendez","year":"2019","journal-title":"Nucleic\nAcids Res."},{"key":"2026081804371274100_cit28","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1021\/ci049714+","article-title":"ZINC\ue5f8A Free\nDatabase of Commercially Available\nCompounds for Virtual Screening","volume":"45","author":"Irwin","year":"2005","journal-title":"J. Chem. Inf.\nModel."},{"key":"2026081804371274100_cit29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s13321-018-0287-6","article-title":"Multi-objective\nde Novo Drug Design\nwith Conditional Graph Generative Model","volume":"10","author":"Li","year":"2018","journal-title":"J.\nCheminf."},{"key":"2026081804371274100_cit30","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1021\/acs.jcim.8b00626","article-title":"De Novo Molecule\nDesign by Translating from Reduced Graphs to SMILES","volume":"59","author":"Poga\u0301ny","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804371274100_cit31","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/nature14236","article-title":"Human-Level Control\nthrough Deep Reinforcement Learning","volume":"518","author":"Mnih","year":"2015","journal-title":"Nature"},{"key":"2026081804371274100_cit32","doi-asserted-by":"publisher","first-page":"5442","DOI":"10.1021\/acs.jmedchem.8b00494","article-title":"Computer-Assisted Discovery of Retinoid\nX Receptor\nModulating Natural Products and Isofunctional Mimetics","volume":"61","author":"Merk","year":"2018","journal-title":"J. Med. Chem."},{"key":"2026081804371274100_cit33","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1021\/acs.molpharmaceut.8b00839","article-title":"Entangled Conditional\nAdversarial Autoencoder for de Novo Drug Discovery","volume":"15","author":"Polykovskiy","year":"2018","journal-title":"Mol. Pharmaceutics"},{"key":"2026081804371274100_cit34","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1038\/s41587-019-0224-x","article-title":"Deep Learning Enables Rapid Identification of Potent\nDDR1 Kinase Inhibitors","volume":"37","author":"Zhavoronkov","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"2026081804371274100_cit35","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-47148-x","article-title":"Optimization\nof Molecules via Deep Reinforcement Learning","volume":"9","author":"Zhou","year":"2019","journal-title":"Sci. Rep."},{"key":"2026081804371274100_cit36","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.1021\/acs.jcim.9b00325","article-title":"Deep Reinforcement Learning for Multiparameter\nOptimization\nin de Novo Drug Design","volume":"59","author":"St\u00e5hl","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804371274100_cit37","unstructured":"Deng, J.; Yang, Z.; Li, Y.; Samaras, D.; Wang, F.\n          Towards Better Opioid Antagonists Using Deep Reinforcement\nLearning. 2020, arXiv:physics\/2004.04768.\narXiv.org e-Print archive. https:\/\/arxiv.org\/abs\/2004.04768."},{"key":"2026081804371274100_cit38","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1016\/j.ddtec.2013.02.001","article-title":"Multi-objective Optimization Methods in Drug Design","volume":"10","author":"Nicolaou","year":"2013","journal-title":"Drug Discovery Today: Technol."},{"key":"2026081804371274100_cit39","doi-asserted-by":"crossref","first-page":"521","DOI":"10.2174\/138620711795767802","article-title":"The Design and Application of Target-Focused\nCompound Libraries","volume":"14","author":"John\nHarris","year":"2020","journal-title":"Comb. Chem. High Throughput\nScreening"},{"key":"2026081804371274100_cit40","unstructured":"Https:\/\/Github.Com\/Alberdom88\/Moo-Denovo."},{"key":"2026081804371274100_cit41","doi-asserted-by":"crossref","unstructured":"Polykovskiy, D.; Zhebrak, A.; Sanchez-Lengeling, B.; Golovanov, S.; Tatanov, O.; Belyaev, S.; Kurbanov, R.; Artamonov, A.; Aladinskiy, V.; Veselov, M.; Kadurin, A.; Johansson, S.; Chen, H.; Nikolenko, S.; Aspuru-Guzik, A.; Zhavoronkov, A.\n          Molecular Sets\n(MOSES): A Benchmarking Platform for Molecular Generation Models. 2019, arXiv:physics\/1811.12823. arXiv.org e-Print\narchive. https:\/\/arxiv.org\/abs\/1811.12823.","DOI":"10.3389\/fphar.2020.565644"},{"key":"2026081804371274100_cit42","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1021\/acs.jcim.8b00839","article-title":"GuacaMol: Benchmarking\nModels for de Novo Molecular Design","volume":"59","author":"Brown","year":"2019","journal-title":"J. Chem.\nInf. Model."},{"key":"2026081804371274100_cit43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization\nDeclares Global Emergency: A Review of the 2019 Novel Coronavirus\n(COVID-19)","volume":"76","author":"Sohrabi","year":"2020","journal-title":"Int. J. Surg."},{"key":"2026081804371274100_cit44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2020.105924","article-title":"Severe\nAcute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus\nDisease-2019 (COVID-19): The Epidemic and the Challenges","volume":"55","author":"Lai","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"2026081804371274100_cit45","unstructured":"Chung, J.; Gulcehre, C.; Cho, K.; Bengio, Y.\n          Empirical Evaluation of Gated\nRecurrent Neural Networks on Sequence Modeling. 2014, arXiv:physics\/1412.3555. arXiv.org e-Print archive. https:\/\/arxiv.org\/abs\/1412.3555."},{"key":"2026081804371274100_cit46","unstructured":"Landrum, G.\n          \n          RDKit: Open-Source\nCheminformatics, 2006."},{"key":"2026081804371274100_cit47","volume-title":"Reinforcement Learning:\nAn Introduction","author":"Sutton","year":"1998","edition":"1"},{"key":"2026081804371274100_cit48","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1021\/ci9800211","article-title":"Chemical\nSimilarity Searching","volume":"38","author":"Willett","year":"1998","journal-title":"J. Chem. Inf. Comput.\nSci."},{"key":"2026081804371274100_cit49","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ci100050t","article-title":"Extended-Connectivity\nFingerprints","volume":"50","author":"Rogers","year":"2010","journal-title":"J. Chem.\nInf. Model."},{"key":"2026081804371274100_cit50","unstructured":"Benhenda, M.\n          \n          ChemGAN Challenge\nfor Drug Discovery: Can AI Reproduce Natural Chemical Diversity?. 2017, arXiv:physics\/1708.08227. arXiv.org e-Print\narchive. https:\/\/arxiv.org\/abs\/1708.08227."},{"key":"2026081804371274100_cit51","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1389200054021799","article-title":"A Comprehensive\nListing of Bioactivation Pathways of Organic Functional Groups","volume":"6","author":"Kalgutkar","year":"2020","journal-title":"Curr. Drug Metab."},{"key":"2026081804371274100_cit52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1517\/17425255.1.1.91","article-title":"Minimising the Potential for Metabolic Activation in\nDrug Discovery","volume":"1","author":"Kalgutkar","year":"2005","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"2026081804371274100_cit53","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1021\/jm901137j","article-title":"New Substructure Filters for Removal\nof Pan Assay Interference\nCompounds (PAINS) from Screening Libraries and for Their Exclusion\nin Bioassays","volume":"53","author":"Baell","year":"2010","journal-title":"J. Med. Chem."},{"key":"2026081804371274100_cit54","unstructured":"Schro\u0308dinger Release 2019-4: BioLuminate; Schro\u0308dinger, LLC: New York,\nNY, 2019."},{"key":"2026081804371274100_cit55","doi-asserted-by":"publisher","first-page":"10493","DOI":"10.1128\/JVI.00959-08","article-title":"Structural Characterization\nof the 1918 Influenza Virus H1N1 Neuraminidase","volume":"82","author":"Xu","year":"2008","journal-title":"J. Virol."},{"key":"2026081804371274100_cit56","doi-asserted-by":"publisher","first-page":"10282","DOI":"10.1021\/jm300871x","article-title":"Structures of Human\nAcetylcholinesterase in Complex with Pharmacologically Important Ligands","volume":"55","author":"Cheung","year":"2012","journal-title":"J. Med. Chem."},{"key":"2026081804371274100_cit57","doi-asserted-by":"publisher","DOI":"10.2020\/02.26.964882","article-title":"Structure of Mpro from\nCOVID-19 Virus and Discovery of Its Inhibitors","author":"Jin","year":"2020","journal-title":"bioRxiv"},{"key":"2026081804371274100_cit58","doi-asserted-by":"publisher","first-page":"1363","DOI":"10.1056\/NEJMra050740","article-title":"Neuraminidase\nInhibitors for Influenza","volume":"353","author":"Moscona","year":"2005","journal-title":"N. Eng. J. Med."},{"key":"2026081804371274100_cit59","doi-asserted-by":"publisher","first-page":"40","DOI":"10.3390\/biom10010040","article-title":"Alzheimer\u2019s\nDisease Pharmacotherapy in Relation to Cholinergic System Involvement","volume":"10","author":"Stanciu","year":"2020","journal-title":"Biomolecules"},{"key":"2026081804371274100_cit60","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/molecules21030362","article-title":"Searching\nfor Multi-Targeting Neurotherapeutics against\nAlzheimer\u2019s: Discovery of Potent AChE-MAO B Inhibitors through\nthe Decoration of the 2H-Chromen-2-One Structural Motif","volume":"21","author":"Pisani","year":"2016","journal-title":"Molecules"},{"key":"2026081804371274100_cit61","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001190.pub2","article-title":"Donepezil for Dementia\nDue to Alzheimer\u2019s Disease","volume":"363","author":"Birks","year":"2006","journal-title":"Cochrane\nDatabase Syst. Rev."},{"key":"2026081804371274100_cit62","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1021\/jm101299d","article-title":"Homodimeric Bis-Quaternary\nHeterocyclic Ammonium Salts as Potent Acetyl- and Butyrylcholinesterase\nInhibitors: A Systematic Investigation of the Influence of Linker\nand Cationic Heads over Affinity and Selectivity","volume":"54","author":"Conejo-Garci\u0301a","year":"2011","journal-title":"J. Med. Chem."},{"key":"2026081804371274100_cit63","doi-asserted-by":"publisher","first-page":"614","DOI":"10.1128\/CMR.11.4.614","article-title":"Protease Inhibitors\nas Antiviral Agents","volume":"11","author":"Patick","year":"1998","journal-title":"Clin. Microbiol. Rev."},{"key":"2026081804371274100_cit64","doi-asserted-by":"publisher","DOI":"10.20944\/preprints202002.0242.v2","article-title":"Potential Therapeutic Agents for\nCOVID-19 Based on\nthe Analysis of Protease and RNA Polymerase Docking","author":"Chang","year":"2020","journal-title":"Preprints"},{"key":"2026081804371274100_cit65","doi-asserted-by":"publisher","first-page":"8809","DOI":"10.1021\/acs.jmedchem.9b02044","article-title":"Automated De Novo Design\nin Medicinal Chemistry: Which Types of Chemistry Does a Generative\nNeural Network Learn?","volume":"63","author":"Grebner","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026081804371274100_cit66","doi-asserted-by":"publisher","first-page":"8667","DOI":"10.1021\/acs.jmedchem.9b02120","article-title":"Current and Future\nRoles of Artificial\nIntelligence in Medicinal Chemistry Synthesis","volume":"63","author":"Struble","year":"2020","journal-title":"J. Med. Chem."},{"key":"2026081804371274100_cit67","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1021\/acs.jcim.8b00698","article-title":"A New Approach for Drug Target and Bioactivity Prediction:\nThe Multifingerprint Similarity Search Algorithm (MuSSeL)","volume":"59","author":"Alberga","year":"2019","journal-title":"J. Chem. Inf. Model."},{"key":"2026081804371274100_cit68","doi-asserted-by":"publisher","first-page":"2233","DOI":"10.3390\/molecules24122233","article-title":"Accelerating\nDrug Discovery by Early Protein Drug Target Prediction Based on a\nMulti-Fingerprint Similarity Search","volume":"24","author":"Montaruli","year":"2019","journal-title":"Molecules"},{"key":"2026081804371274100_cit69","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1080\/17460441.2017.1365056","article-title":"Ligand Efficiency Metrics\nin Drug Discovery: The Pros and Cons from a Practical Perspective","volume":"12","author":"Cavalluzzi","year":"2017","journal-title":"Expert Opin. Drug Discovery"}],"container-title":["Journal of Chemical Information and Modeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/acs.jcim.0c00517","content-type":"application\/pdf","content-version":"vor","intended-application":"unspecified"},{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article-pdf\/60\/10\/4582\/8898531\/ci0c00517.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article-pdf\/60\/10\/4582\/8898531\/ci0c00517.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T09:36:14Z","timestamp":1787045774000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/jcisd8\/article\/60\/10\/4582\/849703\/De-Novo-Drug-Design-of-Targeted-Chemical-Libraries"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,26]]},"references-count":69,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,8,26]]},"published-print":{"date-parts":[[2020,10,26]]}},"URL":"https:\/\/doi.org\/10.1021\/acs.jcim.0c00517","relation":{},"ISSN":["1549-9596","1549-960X"],"issn-type":[{"value":"1549-9596","type":"print"},{"value":"1549-960X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,26]]}}}